RepliGen
RepliGen Repligen
Corporation is a biopharmaceutical company focused on the development of novel
therapeutics for diseases that affect the central nervous system. A number of
drug development programs are currently being conducted to evaluate our naturally
occurring drug candidates in diseases such as schizophrenia, obsessive-compulsive
disorder, bipolar disorder and neurodegeneration.
More
About RepliGen